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Atrial Natriuretic Peptide (ANP), a soluble circulating 
protein, can be amyloidogenic and features ANP-containing 
amyloid deposits are found primarily in the heart [1]. The 
cause for this transition from soluble to insoluble protein in 
Isolated Atrial Amyloidosis (IAA) is yet to be determined, 
and specific structural features that might favour ANP 
fibrillogenesis have not yet been identified. The molecular 
basis of ANP aggregation is thus relevant for modelling the 
amyloidogenesis process as well as for improving delivery 
systems used for amyloidosis treatments. Consequently, the 
precise characterization of in vitro fibril deposits might 
provide insight the true biochemical nature of deposited 
ANP. In this study, we provide detailed analyses of both the 
soluble and deposited forms of ANP in different solution 
conditions. The structure and the morphogenesis of 
aggregates have been monitored by using different 
experimental techniques: Transmission electron microscopy, 
spectrophotometric Congo Red assay, thioflavin T 
fluorescence, FTIR spectroscopy. ANP aggregation displays 
a wide variety of morphologies, from small oligomeric 
filaments to voluminous floccules, and therefore different 
specific processes are likely to be intertwined in the overall 
aggregation. Fibrillar aggregates grow following a 
concentration dependent heterogeneous coagulation 
mechanism, including both protofibril elongation and lateral 
thickening until formation of strictly interconnected amyloid 
material. 
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Platelets are the smallest blood circulating cells involved in 
several pathophysiological events such as haemostasis, 
wound repair, inflammation and cardiovascular disease. 
Although platelets are anucleated particles and inherit their 
protein content from megakaryocytes, they can undergo 
translation events and synthesize selected proteins. Thus, the 
analysis of the platelet proteoma may provide significant 
information on the role that platelets may play in human 
pathology.  
Cystic fibrosis (CF) is a genetic disease evoked by 
mutations in the CFTR gene, located in the long arm of 
chromosome 7 and coding for a protein with ion channel 
activity. Inflammatory lung disease is the primary cause of 
morbidity and mortality in CF, nonetheless mechanisms of 
CF inflammation are still incompletely known. Enhanced 
platelet activation in vivo and ex vivo has been documented 
in CF patients which display also increased circulating 
platelet/PMN and platelet/monocyte complexes, suggesting 
that platelets may be involved in CF inflammation. 
In this work, we pursued a comparative proteomic analysis 
of platelets obtained from healthy donors and CF patient, 
employing two different, but complementary approaches, 
namely the classic 2-DE in association with mass analysis 
and nanoscale ultra-performance LC-MSE. We compared 
these techniques for sensibility, accuracy and data 
reproducibility. We consistently observed that the 
combination of these techniques gives a more detailed 
characterization of the platelet proteome and identified, a 
restricted group of protein differentially expressed in CF 
platelets.  
A comparative analysis of the Gene Ontology was 
performed to evaluate the overall molecular function and the 
potential pathophysiological relevance of these proteins 
within the context of CF inflammation
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